<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3510">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04574050</url>
  </required_header>
  <id_info>
    <org_study_id>IRAS 285303</org_study_id>
    <secondary_id>20/LO/1108</secondary_id>
    <nct_id>NCT04574050</nct_id>
  </id_info>
  <brief_title>SELF-BREATHE RCT for Chronic Breathlessness</brief_title>
  <official_title>A Self - Guided, Internet - Based Intervention for Patients With Chronic Breathlessness (SELF-BREATHE): Feasibility Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King's College Hospital NHS Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A feasibility RCT comprising two groups:

        1. Intervention (SELF-BREATHE in addition to standard NHS care)

        2. Control group (standard / currently available NHS care)
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 3, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 4, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A feasibility RCT comprising two groups:
Intervention (SELF-BREATHE in addition to standard NHS care)
Control group (standard / currently available NHS care)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Single blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility: the number of patients recruited into this study over a 12-month period</measure>
    <time_frame>12 months</time_frame>
    <description>The number of patients recruited into this study over a 12-month period</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cancer</condition>
  <condition>COPD</condition>
  <condition>Asthma</condition>
  <condition>Bronchiectasis Adult</condition>
  <condition>Interstitial Lung Disease</condition>
  <condition>Cystic Fibrosis</condition>
  <condition>Chronic Heart Failure</condition>
  <condition>Sickle Cell Disease</condition>
  <condition>Renal Failure</condition>
  <condition>Liver Failure</condition>
  <condition>Post COVID-19</condition>
  <condition>Dyspnea</condition>
  <arm_group>
    <arm_group_label>SELF-BREATHE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Access to a self -guided, internet -based intervention for patients with chronic breathlessness known as SELF-BREATHE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard / currently available NHS care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SELF-BREATHE</intervention_name>
    <description>A self -guided, internet -based intervention for patients with chronic breathlessness</description>
    <arm_group_label>SELF-BREATHE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults â‰¥ 18 years of age, with the ability to read and type in English

          -  Access to a computer, or tablet or smart phone, with internet access and the ability
             to email

          -  Chronic breathlessness (CB) defined as; breathlessness that persists (&gt;3months)
             despite optimal pharmacological treatment of the underlying disease including cancer,
             chronic obstructive pulmonary disease (COPD),asthma, interstitial lung disease (ILD),
             bronchiectasis, cystic fibrosis (CF) chronic heart failure (CHF), sickle cell disease,
             chronic renal/ liver failure or post COVID-19

          -  Chronic breathlessness at rest or on exertion; MRC dysponea score &gt;2

          -  Willing to engage with short-term self-guided internet-based breathlessness
             intervention (SELF-BREATHE)

          -  Able to provide informed consent

        Exclusion Criteria:

          -  Breathlessness of unknown cause

          -  A primary diagnosis of chronic hyperventilation syndrome

          -  Currently participating in a rehabilitation programme, e.g. pulmonary/cardiac
             rehabilitation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 28, 2020</study_first_submitted>
  <study_first_submitted_qc>October 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2020</study_first_posted>
  <last_update_submitted>October 1, 2020</last_update_submitted>
  <last_update_submitted_qc>October 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Dyspnea</mesh_term>
    <mesh_term>Bronchiectasis</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
    <mesh_term>Anemia, Sickle Cell</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

